Letter From The Editor

Thanks to everyone who asked for more information on the “sartan” contamination recall. Some of you asked how this happened, a few wanted to know the science behind it, and almost everybody wanted to know how the pharmaceutical industry and the FDA were going to fix it. With those comments …

Last week, we had some information on the Da Qing Diabetes study, and I mentioned the problem with availability of the most popular ARB’s. Many of you asked for more information and we are completing a special report on what is going on and some possible solutions. Look to our …

This week Sheri R. Colberg, PhD, FACSM has an interesting feature on exercise and glucose levels. In her in-depth review she presents concepts that may change how you advise your patients on eating before during and after exercise. One of the things that we often do is discount the consumption …

This week we have an interesting post-hoc article on the results of the Da Qing Diabetes study. This retrospective examination looks at how hypertension increases the risk for diabetes and how that in turn increases the risk for cardiovascular disease. There are great details that make this article worth reading, …

Most times when someone dies from the complications of diabetes, the cause of death is heart disease. This is well-documented. Our first article this week looks at new research pointing to how prediabetes can have the same effect. Many of our patients stress their cardiovascular system beyond normal by carrying …

As the National Accounts Manager for a Pharma company and a pharmacist, I have mixed emotions about the use of samples. There is no doubt that from an economic standpoint giving samples to the prescriber to give to the patient is very cost effective; however, as a pharmacist I would …

I have a good friend who recently left her position as head of a kidney and liver transplant center on the west coast of Florida. She had been an ADN at a large hospital and when they decided to open a transplant center, she was tasked with the responsibility of …

Have you ever noticed that when an adult over 40 starts on both meal-time and long-acting insulin, they will refuse to acknowledge that they could possibly have developed type 1 diabetes? Since most of those patients will never see an endocrinologist and have an antibody test, they will never really …

One of our brand managers in our office in Atlanta made the decision to move back to California and return to sales management. One of the things he left behind was a “standing desk.” There were four other people who wanted the desk, so we held a lottery. As you …

Our good friend at Diabetes Investor, David Kliff, has made a point of focusing on the difficulty of a patient’s success just because we have “whizbang” apps and devices to make glucose control almost automatic. The data shows he is probably right, as keeping patients on medications and causing them …